Page last updated: 2024-10-25

chlorpropamide and Hemorrhagic Disorders

chlorpropamide has been researched along with Hemorrhagic Disorders in 1 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Hemorrhagic Disorders: Spontaneous or near spontaneous bleeding caused by a defect in clotting mechanisms (BLOOD COAGULATION DISORDERS) or another abnormality causing a structural flaw in the blood vessels (HEMOSTATIC DISORDERS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Augustyniak, W1
Giermaziak, H1
Gebicki, L1

Other Studies

1 other study available for chlorpropamide and Hemorrhagic Disorders

ArticleYear
[Hemorrhagic drug-induced thrombopenic purpura of allergic origin].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1980, Mar-15, Volume: 33, Issue:6

    Topics: Aged; Chlorpropamide; Diabetes Mellitus; Drug Hypersensitivity; Female; Hemorrhagic Disorders; Human

1980